Search Results
You are looking at 1 - 1 of 1 items for
- Author: GB Pozzan x
- Refine by access: Content accessible to me x
Search for other papers by D Armanini in
Google Scholar
PubMed
Search for other papers by P Spinella in
Google Scholar
PubMed
Search for other papers by M Simoncini in
Google Scholar
PubMed
Search for other papers by A Basso in
Google Scholar
PubMed
Search for other papers by S Zovato in
Google Scholar
PubMed
Search for other papers by GB Pozzan in
Google Scholar
PubMed
Search for other papers by CB De Palo in
Google Scholar
PubMed
Search for other papers by G Bucciante in
Google Scholar
PubMed
Search for other papers by I Karbowiak in
Google Scholar
PubMed
We have studied 16 patients with anorexia nervosa (11 with a stabilised weight loss and 5 in the weight-losing phase), 11 healthy controls, and 10 patients with Cushing's syndrome, by measuring plasma cortisol (by enzyme-immunoassay), ACTH (by RIA), corticosteroid (Type I-mineralocorticoid and Type II-glucocorticoid) receptors in mononuclear leukocytes (by radio-receptor assay), and lymphocyte subpopulations (by cytofluorimetry). In anorexic patients with a stabilised weight loss and in Cushing's syndrome the mean value of both Type I and Type II corticosteroid receptors in mononuclear leukocytes was significantly lower than in controls. The correlation between Type II receptors and plasma cortisol was inverse in stabilised anorexia nervosa and in Cushing's syndrome, and direct in healthy controls. Anorexic patients in the weight-losing phase showed a significant increase in plasma cortisol levels and a normal number of Type II receptors. From these results we hypothesise that in anorexia nervosa there is a progression from an increase in plasma cortisol in the weight-losing phase, to a concomitant decrease in Type II receptors when the disease is stabilised.
